ATE188253T1 - Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen - Google Patents

Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen

Info

Publication number
ATE188253T1
ATE188253T1 AT92924122T AT92924122T ATE188253T1 AT E188253 T1 ATE188253 T1 AT E188253T1 AT 92924122 T AT92924122 T AT 92924122T AT 92924122 T AT92924122 T AT 92924122T AT E188253 T1 ATE188253 T1 AT E188253T1
Authority
AT
Austria
Prior art keywords
collagen
collagens
synthesis
recombinant dna
human
Prior art date
Application number
AT92924122T
Other languages
English (en)
Inventor
Darwin J Prockop
Lenna Ala-Kokko
Andrzej Fertala
Aleksander Sieron
Kari I Kivirikko
Amy Geddis
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25121036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE188253(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Jefferson filed Critical Univ Jefferson
Application granted granted Critical
Publication of ATE188253T1 publication Critical patent/ATE188253T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT92924122T 1991-10-23 1992-10-22 Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen ATE188253T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78089991A 1991-10-23 1991-10-23
PCT/US1992/009061 WO1993007889A1 (en) 1991-10-23 1992-10-22 Synthesis of human procollagens and collagens in recombinant dna systems

Publications (1)

Publication Number Publication Date
ATE188253T1 true ATE188253T1 (de) 2000-01-15

Family

ID=25121036

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92924122T ATE188253T1 (de) 1991-10-23 1992-10-22 Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen

Country Status (11)

Country Link
US (1) US5405757A (de)
EP (2) EP0962529A1 (de)
JP (2) JP3302017B2 (de)
AT (1) ATE188253T1 (de)
AU (2) AU680606B2 (de)
CA (1) CA2121698C (de)
DE (1) DE69230502T3 (de)
DK (1) DK0625048T4 (de)
ES (1) ES2143478T5 (de)
GR (1) GR3033022T3 (de)
WO (1) WO1993007889A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020142391A1 (en) * 1991-06-12 2002-10-03 Kivirikko Kari I. Synthesis of human procollagens and collagens in recombinant DNA systems
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
WO1995011920A1 (en) * 1993-10-25 1995-05-04 Teijin Limited Purified human chondrocalcin, process for producing the same, and utilization thereof
EP0759932A4 (de) * 1994-05-11 1997-11-19 Organo Genesis Inc Kollagen aus zellkulturen
US6713662B1 (en) * 1994-07-27 2004-03-30 Pharming Intellectual Property B.V. Production of collagen in the milk of transgenic mammals
CN1198775A (zh) * 1995-08-08 1998-11-11 托马斯杰弗逊大学 重组c－蛋白酶及其加工、方法和用途
JP4003836B2 (ja) 1995-08-31 2007-11-07 ザ・ユニバーシティ・オブ・マンチェスター 新規プロコラーゲン
WO1997014431A1 (en) * 1995-10-20 1997-04-24 Collagen Corporation Production of recombinant procollagen in yeast
CA2237900A1 (en) * 1995-11-13 1997-05-22 Fibrogen, Inc. Type ix collagen and chimeras
US5773248A (en) * 1995-11-13 1998-06-30 Uab Research Foundation Nucleic acid encoding a human α3(IX) collagen protein and method of producing the protein recombinantly
JP2000508544A (ja) * 1996-04-12 2000-07-11 ファイブローゲン，インコーポレーテッド 組換えｄｎａ系におけるヒトプロコラーゲンおよびコラーゲンの合成
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
AU780813B2 (en) * 1996-10-29 2005-04-21 Commonwealth Scientific And Industrial Research Organisation Stable expression of triple helical proteins
US6451557B1 (en) * 1996-10-29 2002-09-17 Commonwealth Scientific And Industrial Research Organisation Method for producing, in yeast, a hydroxylated triple helical protein, and yeast host cells useful in said method
AUPO331096A0 (en) * 1996-10-29 1996-11-21 Commonwealth Scientific And Industrial Research Organisation Collagen products
FR2757874B1 (fr) * 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
GB9704305D0 (en) * 1997-03-01 1997-04-23 Univ Manchester Procollagen assembly
US6150081A (en) 1997-12-24 2000-11-21 Fuji Photo Film B.V. Silver halide emulsions with recombinant collagen suitable for photographic application and also the preparation thereof
NL1007908C2 (nl) * 1997-12-24 1999-06-25 Fuji Photo Film Bv Zilverhalide-emulsies met recombinant collageen die geschikt zijn voor fotografische toediening alsmede de bereiding daarvan.
DE19812713A1 (de) * 1998-03-24 1999-09-30 Merck Patent Gmbh Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff
JP2000125872A (ja) * 1998-09-07 2000-05-09 Terumo Corp 三量体キメラタンパク質およびキメラタンパク質を含有するコラーゲンマトリックス
DE60040012D1 (de) * 1999-11-12 2008-10-02 Fibrogen Inc Rekombinantes gelatin in impstoffen
CA2399371A1 (en) * 1999-11-12 2001-05-17 Fibrogen, Inc. Animal collagens and gelatins
EP1504033A2 (de) * 2002-05-03 2005-02-09 Millenium Biologix Inc. Bindegewebe stimulierende peptide
MXPA05002669A (es) 2002-09-13 2005-08-19 Ocular Sciences Inc Dispositivos y metodos para mejorar la vision.
GB0309064D0 (en) 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
CN1972643A (zh) 2004-05-20 2007-05-30 库柏维景公司 用于提高视力的角膜覆盖物和波前像差矫正
KR101304735B1 (ko) * 2005-03-31 2013-09-05 오사까후 ３중 나선구조를 갖는 단백질의 제조방법
AU2012200573B2 (en) * 2005-03-31 2013-11-07 Fuso Pharmaceutical Industries, Ltd. "Process for production of protein having triple-helical structure"
WO2007041627A1 (en) 2005-10-03 2007-04-12 Pinsky Mark A Compositions and methods for improved skin care
US20080081353A1 (en) * 2006-09-29 2008-04-03 Universite Laval Production of recombinant human collagen
AU2008345068A1 (en) * 2007-12-26 2009-07-09 Mark A. Pinsky Collagen formulations for improved skin care
CA2721507C (en) * 2008-04-18 2017-10-03 Collplant Ltd. Methods of generating and using procollagen
CN102325882A (zh) 2008-12-22 2012-01-18 国立大学法人北海道大学 具有三螺旋结构的蛋白质物质及其制造方法
EP2701508A4 (de) * 2011-04-26 2015-01-07 Univ Leland Stanford Junior Herstellung und abgabe eines stabilen kollagens
TW201408695A (zh) * 2012-08-30 2014-03-01 Body Organ Biomedical Corp 重組載體及應用其而產生之轉基因魚卵與生物材料
FR3033697B1 (fr) * 2015-03-17 2020-03-27 Universite Pierre Et Marie Curie (Paris 6) Suspensions de collagene injectables, leur procede de preparation et leurs utilisations, notamment pour la formation de matrices denses de collagene
WO2020232017A2 (en) * 2019-05-14 2020-11-19 Provenance Biofabrics, Inc. Expression of modified proteins in a peroxisome
KR102135976B1 (ko) * 2019-10-24 2020-07-20 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 펩타이드 및 이를 이용한 방법
DE102021202830A1 (de) 2021-03-23 2022-09-29 Gelita Ag Rekombinantes Typ II-Kollagen zur therapeutischen Verwendung
CN119173524A (zh) 2022-04-04 2024-12-20 斯威夫特制药有限责任公司 在植物中产生的重组蜘蛛丝强化的胶原蛋白及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5045449A (en) * 1989-06-14 1991-09-03 Thomas Jefferson University Methods of detecting a genetic predisposition for vascular aneurysms
US5136021A (en) * 1990-02-27 1992-08-04 Health Research, Inc. TNF-inhibitory protein and a method of production

Also Published As

Publication number Publication date
JP2002255999A (ja) 2002-09-11
AU4441497A (en) 1998-02-12
DK0625048T4 (da) 2006-02-20
EP0625048A1 (de) 1994-11-23
HK1010334A1 (en) 1999-06-17
EP0625048B1 (de) 1999-12-29
EP0625048B2 (de) 2005-10-26
DE69230502T3 (de) 2006-05-24
EP0962529A1 (de) 1999-12-08
DK0625048T3 (da) 2000-05-29
JP3302017B2 (ja) 2002-07-15
GR3033022T3 (en) 2000-08-31
CA2121698C (en) 2010-05-18
AU3055592A (en) 1993-05-21
ES2143478T3 (es) 2000-05-16
ES2143478T5 (es) 2006-05-16
WO1993007889A1 (en) 1993-04-29
DE69230502T2 (de) 2000-08-10
EP0625048A4 (de) 1995-04-05
CA2121698A1 (en) 1993-04-29
AU680606B2 (en) 1997-08-07
US5405757A (en) 1995-04-11
JPH07501939A (ja) 1995-03-02
DE69230502D1 (de) 2000-02-03

Similar Documents

Publication Publication Date Title
ATE188253T1 (de) Synthese von humanen prokollagenen und kollagenen in rekombinanten dna-systemen
ATE373672T1 (de) Synthese von methoxynukleoside und enzymatische nukleisäure moleküle
EP0846262A4 (de) Abbildung von spektroskopie von gewebe und anderen stark streuenden medien, basierend auf fluoreszenz lebensdauer
ATE114169T1 (de) Morphogenetisches knochenprotein.
ATE343635T1 (de) Bmp-11 zusammenstellungen
EA200200755A1 (ru) Опосредованная рецептором nogo блокада роста аксонов
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DE69736840D1 (de) Synthese von nukleosiden und polynukleotiden
DE69435218D1 (de) Regulation der Genexpression von bcl-2
ATE179211T1 (de) Menschliche il-3-varianten
PT1011723E (pt) Factor de crescimento tumorigenico de 88 kda e antagonistas
DE69821793D1 (de) Neuronale verwendungen des bmp-11
BR0014183A (pt) Composições farmaceuticas e metodos de uso de proteìna relacionada frizzled secretada
ATE233553T1 (de) Mono-und disulfosubstituierte anthrachinone und deren verwendung zur behandlung von knochenmatrixerkrankungen
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE222901T1 (de) Carboxylsubstituierte chromanderivate zur verwendung als beta 3 adrenorezeptor-agonisten
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
BR9712767A (pt) Expressão especìfica para tecido de proteìna de retinoblastoma
DE69022776D1 (de) Verwendung von keramischen Materialen als Ersatzmaterialien für lebendes Gewebe.
ATE208218T1 (de) Membransystem zur gesteuerten geweberegeneration bei erkrankungen des zahnhalteapparates
TR199902564T2 (xx) K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�.
DE69332702D1 (de) Verwendung der gensequenz eines promotors zur behandlung rheumatischer erkrankungen
DE69617994D1 (de) Verwendung von sulfonamiden zur kontrolle von biobewuchs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0625048

Country of ref document: EP